IRF6 antibody (AA 115-300)
Quick Overview for IRF6 antibody (AA 115-300) (ABIN6142535)
Target
See all IRF6 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 115-300
-
Sequence
- DIPQPQGSII NPGSTGSAPW DEKDNDVDEE DEEDELDQSQ HHVPIQDTFP FLNINGSPMA PASVGNCSVG NCSPEAVWPK TEPLEMEVPQ APIQPFYSSP ELWISSLPMT DLDIKFQYRG KEYGQTMTVS NPQGCRLFYG DLGPMPDQEE LFGPVSLEQV KFPGPEHITN EKQKLFTSKL LDVMDR
-
Cross-Reactivity
- Human, Mouse, Rat
-
Characteristics
- Polyclonal Antibodies
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 115-300 of human IRF6 (NP_006138.1).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000
-
Comment
-
HIGH QUALITY
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- IRF6 (Interferon Regulatory Factor 6 (IRF6))
-
Alternative Name
- IRF6
-
Background
- This gene encodes a member of the interferon regulatory transcription factor (IRF) family. Family members share a highly-conserved N-terminal helix-turn-helix DNA-binding domain and a less conserved C-terminal protein-binding domain. The encoded protein may be a transcriptional activator. Mutations in this gene can cause van der Woude syndrome and popliteal pterygium syndrome. Mutations in this gene are also associated with non-syndromic orofacial cleft type 6. Alternate splicing results in multiple transcript variants.,IRF6,LPS,OFC6,PIT,PPS,PPS1,VWS,VWS1,Epigenetics & Nuclear Signaling,Transcription Factors,Immunology & Inflammation,Cytokines,Interferons,Cell Intrinsic Innate Immunity Signaling Pathway,Stem Cells,Embryonic Stem Cells,IRF6
-
Molecular Weight
- 41 kDa/53 kDa
-
Gene ID
- 3664
-
UniProt
- O14896
Target
-